TY - JOUR
T1 - Genetic Analysis of Copy Number Variation in Large Chorangiomas
AU - Sirotkina, Meeli
AU - Douroudis, Konstantinos
AU - Westgren, Magnus
AU - Papadogiannakis, Nikos
N1 - Funding Information:
The authors would like to thank Dr Anna Lindstrand and Maria Pettersson from the Department of Molecular Medicine and Surgery, Centre for Molecular Medicine Karolinska Institutet, Stockholm, Sweden, for carrying out the genotyping and data analysis and helping with interpretation of the results. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
Publisher Copyright:
© 2018, Society for Pediatric Pathology All rights reserved.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Introduction: Chorangioma (CA) is the most common nontrophoblastic, vascular tumor-like lesion of the placenta with a reported incidence of 0.5% to 1% in all examined placentas. The underlying molecular mechanisms of CAs are still poorly elucidated, and a systematic investigation of the genetic background of CAs has not previously been done. Materials and Methods: Tissue biopsies from 8 large (>40 mm) histologically confirmed CAs and 8 unaffected matched placenta controls, along with standard control DNA samples were analyzed for large genomic deletions and duplications using array comparative genomic hybridization (array-CGH) method. Results: Array-CGH analysis revealed no rare or novel copy number variants in the CA samples compared with either standard control DNA or unaffected placenta DNA from the same individual. Discussion: In this study, a systematic genetic investigation of 8 large CAs failed to demonstrate any large-scale pathogenic genetic changes. This lack of association might support a nongenetic, nontumorous origin of these lesions; however, additional genetic studies focusing on smaller genomic alterations are required to fully assess any possible genetic contribution.
AB - Introduction: Chorangioma (CA) is the most common nontrophoblastic, vascular tumor-like lesion of the placenta with a reported incidence of 0.5% to 1% in all examined placentas. The underlying molecular mechanisms of CAs are still poorly elucidated, and a systematic investigation of the genetic background of CAs has not previously been done. Materials and Methods: Tissue biopsies from 8 large (>40 mm) histologically confirmed CAs and 8 unaffected matched placenta controls, along with standard control DNA samples were analyzed for large genomic deletions and duplications using array comparative genomic hybridization (array-CGH) method. Results: Array-CGH analysis revealed no rare or novel copy number variants in the CA samples compared with either standard control DNA or unaffected placenta DNA from the same individual. Discussion: In this study, a systematic genetic investigation of 8 large CAs failed to demonstrate any large-scale pathogenic genetic changes. This lack of association might support a nongenetic, nontumorous origin of these lesions; however, additional genetic studies focusing on smaller genomic alterations are required to fully assess any possible genetic contribution.
KW - array comparative genomic hybridization
KW - chorangioma
KW - copy number variants
UR - http://www.scopus.com/inward/record.url?scp=85058934351&partnerID=8YFLogxK
U2 - 10.1177/1093526618811744
DO - 10.1177/1093526618811744
M3 - Article
C2 - 30428272
AN - SCOPUS:85058934351
SN - 1093-5266
VL - 22
SP - 236
EP - 242
JO - Pediatric and Developmental Pathology
JF - Pediatric and Developmental Pathology
IS - 3
ER -